Immunology

Public Health 

The end of the AIDS epidemic?

The US government wants to reduce new cases of AIDS by 90% by 2030, but faces the challenge of reaching vulnerable groups

By

Public health

The fight against measles

The goal of eliminating the transmission of measles worldwide by 2020 is far from being achieved

By

Health

Life-saving vaccines

Butantan produces 100 million doses of nine vaccines each year

By

Health

Partnership for a dengue vaccine

A Butantan vaccine in final trials leads to a US$100 million agreement with a US pharma company

By

Tropical diseases

A center for safeguarding health in the Amazon

Founded in 1936, the Evandro Chagas Institute produces world-leading research on infectious and parasitic diseases and environmental issues

By

Interview

Pedro Fernando da Costa Vasconcelos: The return of yellow fever and Zika

Discoverer of more than 100 species of viruses in the Amazon, the virologist from the state of Pará says it's just a matter of time before there are new outbreaks of the two diseases

By and

Cover

The reasons for the decline in vaccinations

At least nine factors contribute to a reduction in childhood immunization and increase the risk of the reappearance of serious illnesses

By

Epidemiology

West Nile virus isolated in Brazil

The West Nile fever virus was isolated in Brazil for the first time by researchers at the Evandro Chagas Institute

By

Public Health

Africa hit by new Ebola outbreak

In May, the city of Mbandaka confirmed its first cases of Ebola, which have spread from an outbreak in nearby rural areas

By

PUBLIC HEALTH 

A barrier against HIV

New medication to prevent transmission of the AIDS virus is adopted and evaluated in Brazil

By

OBITUARY

The malaria vaccine pioneer

Ruth Nussenzweig died in New York City at 89 from a pulmonary embolism

By

Retrospect

A controversial vaccine

Early attempts to prevent yellow fever in Brazil, in 1883, were beset by controversy

By

Public Health

Three announcements on yellow fever

Recent announcements regarding yellow fever have included both good news and bad news

By

Cover

The mechanisms of aging

Studies of living cells and organisms identify genetic and molecular phenomena associated with physical and mental decline

By and

PUBLIC HEALTH

Examining the yellow fever vaccine

Scientific evidence indicates that the fractionated dose produces a protective effect, but there is no consensus about its duration

By

Cover

The monkey alarm

Yellow fever is decimating populations of wild primates, whose deaths indicate areas where the virus is transmitted

By

Immunology

Zika vaccines edge closer

Zika vaccine candidates presented encouraging results on humans

By

Epidemiology

No Zika at the Olympic Games in Rio

No Zika at the Olympic Games in Rio

By

careers

The music stopped

Gabriel Victora left his career as a pianist to dedicate himself to immunology

By

public health

Tracking yellow fever

How monkeys help us understand the virus' dispersal

By

Immunology

Advances against AIDS

An experimental HIV vaccine elicited immune responses in nearly 400 volunteers

By

MEDICINE

HPV and male cancer

How long it takes HPV to cause genital warts or precancerous lesions

By

Robert Tesh

Robert Tesh: Arbovirus hunter

Expert talks about Brazil’s performance during the Zika epidemic

By

IMMUNOLOGY

Dengue may attenuate Zika

Dengue infection may moderate cases of Zika

By

Epidemiology

Breaking boundaries

Real-time analyses reveal trajectory of Zika virus across the Americas

By and

immunology

Zika virus vaccine will be tested in Brazil

Zika virus vaccine will be tested in Brazil

By

Cover

The mechanisms of aging

Studies identify phenomena associated with physical and mental decline

By and

Epidemiology

The threat of yellow fever

Yellow fever cases is bringing back the fear of an urban epidemic in Brazil

By

HEALTH

Zika, a collaboration to characterize a syndrome

Interdisciplinary work has confirmed that the Zika virus causes microcephaly and other types of brain damage in perinatally-infected infants

By

Jorge Kalil

Jorge Kalil: Tamer of Crises

The immunologist talks about his experience as head of InCor and Butantan

By